Vanguard Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6M | Sell |
|
|||||
|
2025
Q1 | $81.2M | Sell |
|
|||||
|
2024
Q4 | $96.8M | Sell |
|
|||||
|
2024
Q3 | $104M | Buy |
|
|||||
|
2024
Q2 | $112M | Buy |
|
|||||
|
2024
Q1 | $92.1M | Buy |
|
|||||
|
2023
Q4 | $94.7M | Buy |
|
|||||
|
2023
Q3 | $129M | Sell |
|
|||||
|
2023
Q2 | $126M | Buy |
|
|||||
|
2023
Q1 | $116M | Buy |
|
|||||
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $69.4M | Buy |
|
|||||
|
2022
Q2 | $101M | Buy |
|
|||||
|
2022
Q1 | $161M | Buy |
|
|||||
|
2021
Q4 | $111M | Buy |
|
|||||
|
2021
Q3 | $137M | Sell |
|
|||||
|
2021
Q2 | $193M | Buy |
|
|||||
|
2021
Q1 | $136M | Buy |
|
|||||
|
2020
Q4 | $122M | Buy |
|
|||||
|
2020
Q3 | $62.7M | Sell |
|
|||||
|
2020
Q2 | $95.4M | Buy |
|
|||||
|
2020
Q1 | $45.2M | Buy |
|
|||||
|
2019
Q4 | $161M | Buy |
|
|||||
|
2019
Q3 | $196M | Sell |
|
|||||
|
2019
Q2 | $220M | Buy |
|
|||||
|
2019
Q1 | $286M | Buy |
|
|||||
|
2018
Q4 | $238M | Buy |
|
|||||
|
2018
Q3 | $451M | Buy |
|
|||||
|
2018
Q2 | $484M | Buy |
|
|||||
|
2018
Q1 | $404M | Buy |
|
|||||
|
2017
Q4 | $402M | Sell |
|
|||||
|
2017
Q3 | $372M | Buy |
|
|||||
|
2017
Q2 | $372M | Buy |
|
|||||
|
2017
Q1 | $418M | Buy |
|
|||||
|
2016
Q4 | $419M | Buy |
|
|||||
|
2016
Q3 | $387M | Buy |
|
|||||
|
2016
Q2 | $422M | Buy |
|
|||||
|
2016
Q1 | $376M | Sell |
|
|||||
|
2015
Q4 | $365M | Sell |
|
|||||
|
2015
Q3 | $342M | Buy |
|
|||||
|
2015
Q2 | $367M | Buy |
|
|||||
|
2015
Q1 | $331M | Buy |
|
|||||
|
2014
Q4 | $358M | Buy |
|
|||||
|
2014
Q3 | $418M | Sell |
|
|||||
|
2014
Q2 | $479M | Buy |
|
|||||
|
2014
Q1 | $555M | Buy |
|
|||||
|
2013
Q4 | $522M | Buy |
|
|||||
|
2013
Q3 | $441M | Buy |
|
|||||
|
2013
Q2 | $388M | Buy |
|